Stock listing
Biosenic
Selected listing: A14NHV · LS · EUR · DE
Biosenic (Lang & Schwarz: A14NHV), Health Technology. Latest release Dec 14, 2025: BioSenic : Report from Auditor on ESEF format 2024 Annual Report.
- Ticker
- Lang & Schwarz: A14NHV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Biosenic
BioSenic : Report from Auditor on ESEF format 2024 Annual Report
December 14, 2025
BioSenic : appoints CarKath SRL, represented by Mr Eric Halioua, as chairman of the board of directors
September 25, 2025
BioSenic : provides an update on the preparation of the annual accounts and annual report for the financial year ending on 31 December 2024
August 29, 2025
BioSenic : announces the homologation by the Enterprise Court of BioSenic's amicable agreements with five main creditors to restructure over €22 million of debt and appointment of two new independent directors
August 4, 2025
BioSenic : announces partnership with 4Moving Biotech and secures its financing.
July 1, 2025
Research Biosenic
Alternate listings
BIOS:EURONEXT
BE · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
0R55:LSE
GB · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
A14NHV:LSX
DE · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
BT1:FWB
DE · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
BIOSB:AQUISEU
GB · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
BT1:SWB
DE · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.
BIOSB:AQUISUK
GB · EUR
Alternate listing for Biosenic; the primary context on this page is A14NHV:LS.